BGI has been involved in COVID-19 response efforts from the beginning of the outbreak. This direct experience, as well as our long history as one of the world’s leading genomics companies, positions us well to assist researchers understand further the molecular structure of SARS-CoV-2 and pathogenesis of the disease COVID-19. Please review some example research questions and our solutions below.
Free On-Demand Webinar
Register for and view on-demand our webinar introducing SARS-CoV-2 with a live demonstration of the system.